Targeting the Liver in the Metabolic Syndrome: Evidence from Animal Models

By  

Current Pharmaceutical Design, Vol. 13, Iss. 21, 2007-07 ,pp. : 2199-2207

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 9, Iss. 4, 2009-08 ,pp. : 400-414

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Targeting the Endocannabinoids: Implications for the Treatment of Obesity, Metabolic Syndrome, Drug Abuse and Smoking Cessation

By  

Current Medicinal Chemistry, Vol. 13, Iss. 22, 2006-09 ,pp. : 2669-2680

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging Metabolomics Biomarkers of Polycystic Ovarian Syndrome; Targeting the Master Metabolic Disrupters for Diagnosis and Treatment

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 3, 2018-04 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Syndrome Targets

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 5, 2004-10 ,pp. : 431-439

Bentham Science Publishers

Access to resources Recommend Favorite